GSK2983559 free acid
Modify Date: 2024-02-13 18:26:10
GSK2983559 free acid structure
|
Common Name | GSK2983559 free acid | ||
|---|---|---|---|---|
| CAS Number | 1579965-12-0 | Molecular Weight | 538.534 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 823.6±75.0 °C at 760 mmHg | |
| Molecular Formula | C21H23N4O7PS2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 451.9±37.1 °C | |
Use of GSK2983559 free acidGSK2983559 free acid (compound 3) is a potent, specific and oral bioavailable receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 free acid has excellent activity in blocking many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples[1]. |
| Name | 2-({4-(1,3-Benzothiazol-5-ylamino)-6-[(2-methyl-2-propanyl)sulfonyl]-7-quinazolinyl}oxy)ethyl dihydrogen phosphate |
|---|---|
| Synonym | More Synonyms |
| Description | GSK2983559 free acid (compound 3) is a potent, specific and oral bioavailable receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 free acid has excellent activity in blocking many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples[1]. |
|---|---|
| Target |
RIP2[1] |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 823.6±75.0 °C at 760 mmHg |
| Molecular Formula | C21H23N4O7PS2 |
| Molecular Weight | 538.534 |
| Flash Point | 451.9±37.1 °C |
| Exact Mass | 538.074585 |
| LogP | 0.55 |
| Vapour Pressure | 0.0±3.1 mmHg at 25°C |
| Index of Refraction | 1.675 |
| 2-({4-(1,3-Benzothiazol-5-ylamino)-6-[(2-methyl-2-propanyl)sulfonyl]-7-quinazolinyl}oxy)ethyl dihydrogen phosphate |
| Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, dihydrogen phosphate (ester) |